Welcome to LookChem.com Sign In|Join Free

CAS

  • or

34753-27-0

Post Buying Request

34753-27-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

34753-27-0 Usage

Uses

Ethyl 3-oxo-6-phenyl-2,3-dihydro-4-pyridazinecarboxylate is used as a reactant in the chlorination and amidation of 3-?aminopyridazine derivatives with atypical antidepressant, serotonergic and dopaminergic activity.

Check Digit Verification of cas no

The CAS Registry Mumber 34753-27-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,7,5 and 3 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 34753-27:
(7*3)+(6*4)+(5*7)+(4*5)+(3*3)+(2*2)+(1*7)=120
120 % 10 = 0
So 34753-27-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H12N2O3/c1-2-18-13(17)10-8-11(14-15-12(10)16)9-6-4-3-5-7-9/h3-8H,2H2,1H3,(H,15,16)

34753-27-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 6-oxo-3-phenyl-1H-pyridazine-5-carboxylate

1.2 Other means of identification

Product number -
Other names Ethyl 6-phenyl-2H-pyridazin-3-one-4-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:34753-27-0 SDS

34753-27-0Relevant articles and documents

Design, synthesis and bioevaluation of 3-oxo-6-aryl-2,3-dihydropyridazine-4-carbohydrazide derivatives as novel xanthine oxidase inhibitors

Zhang, Lichao,Wang, Sibo,Yang, Mingzheng,Shi, Ailong,Wang, He,Guan, Qi,Bao, Kai,Zhang, Weige

, p. 1818 - 1823 (2019)

In view of expanding the structure activity relationship of xanthine oxidase inhibitors, a series of 3-oxo-6-aryl-2,3-dihydropyridazine-4-carbohydrazide/carboxylic acid derivatives were designed by molecular docking and synthesized. All the target compoun

New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking

Ragusa, Giulio,Gómez-Ca?as, María,Morales, Paula,Rodríguez-Cueto, Carmen,Pazos, María R.,Asproni, Battistina,Cichero, Elena,Fossa, Paola,Pinna, Gerard A.,Jagerovic, Nadine,Fernández-Ruiz, Javier,Murineddu, Gabriele

, p. 398 - 412 (2017/01/16)

In the last few years, cannabinoid type-2 receptor (CB2R) selective ligands have shown a great potential as novel therapeutic drugs in several diseases. With the aim of discovering new selective cannabinoid ligands, a series of pyridazinone-4-c

3-Aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activities

Wermuth,Schlewer,Bourguignon,Maghioros,Bouchet,Moire,Kan,Worms,Biziere

, p. 528 - 537 (2007/10/02)

Minaprine [3[(β-morpholinoethyl)amino]4-methyl-6-phenylpyridazine dihydrochloride] is active in most animal models of depression and exhibits in vivo a dual dopaminomimetic and serotoninomimetic activity profile. In an attempt to dissociate these two effe

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 34753-27-0